Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
4.84
+0.26 (5.68%)
At close: May 12, 2026, 4:00 PM EDT
4.94
+0.10 (2.06%)
After-hours: May 12, 2026, 7:57 PM EDT
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
| Name | Position |
|---|---|
| Colonel Kevin Chung FACP, M.D. | Chief Medical Officer |
| Dr. H. David Humes M.D. | Co-Founder & Scientific Advisor |
| Mr. Bradford K. Towne CPA | Controller & Principal Accounting Officer |
| Mr. Eric Schlorff | CEO, Treasurer, President & Executive Director |
| Mr. Sai P. Iyer Ph.D. | Senior Vice President of Medical Affairs & Research |
| Mr. Tim Varacek | Senior Vice President of Commercial & Business Operations |
| Mr. Tom Mullen | Vice President of Operations & Product Development |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | S-1/A | ea0289387-s1a1_seastar.htm |
| 2026-04-29 | DEF 14A | icu20260401_def14a.htm |
| 2026-04-28 | S-1 | ea0287377-s1_seastar.htm |
| 2026-04-28 | POS AM | ea028737704-posam5_seastar.htm |
| 2026-03-25 | 10-K | icu20251231_10k.htm |
| 2026-01-20 | 8-K | icu20260117_8k.htm |
| 2025-12-23 | 8-K/A | icu20251223_8ka.htm |
| 2025-12-18 | 8-K | icu20251217_8k.htm |
| 2025-11-17 | 8-K | icu20251111c_8k.htm |
| 2025-11-14 | DEF 14A | ea0263820-02.htm |